SYNT

Synthesis modules hot cell

SYNT cell has been designed to host automatic radiopharmaceutical synthesis modules, offering a controlled and safe environment in compliance with the latest GMP guidelines.

Its inflatable seals are granting an ISO 10648:2 air tightness while the ventilation system provides a GMP class B clean air environment.

Are you interested in this product?

The AISI 316L stainless steel inner finishing, the complete extraction of the tray module, the air-tight pass-through system for radio fluids and gases make SYNT the ideal equipment for any synthesis process.

As an option, each box of the SYNT 1 and SYNT 2 may be equipped with a specific shielded waste drawer with automatic door (SYNT WASTE DRAWER) that allows the positioning of max n.3 IBA Synthera® modules and, when the synthesis is over, grants the automatic dropping and storing for decaying of the spent cassettes inside the shielded drawer.

REFERENCES

NORTH AMERICA

Alberta Health University
Edmonton, Canada
University of Saskatchewan
Saskatoon, Canada
TB Regional Research Institute
Thunder Bay, Canada

University of Colorado
Aurora CO, United States of America
SOFIE Bioscience
Gilroy CA, United States of America
University of Minnesota
Minneapolis MN, United States of America

A.A.A. Advanced Accelerator Applications
New Jersey, United States of America
NCM
New York NY, United States of America
SOFIE Bioscience
Romeoville IL, United States of America

SOFIE Bioscience
Sanford FL, United States of America
SOFIE Bioscience
Somerset NJ, United States of America
SOFIE Bioscience
Sterling VA, United States of America

Nemours Foundation DuPont Hospital
Wilmington DE, United States of America

LATIN AMERICA

I.B.F.
Rio Preto, Brazil
H.S.L.
Sao Paulo, Brazil
CICANUM
San Josè, Costa Rica

AFRICA

Clinique Athena
Costantine, Algeria
EHPM
Tizi, Ouzou, Algeria
AMIL
Nairobi, Kenya

MIDDLE EAST

Ibsar Cancer Center
Al-Najaf, Iraq
Hadassah Hospital
Hadassah, Israel
Muscat PET Center (NMIC)
Muscat, Oman

EUROPE

BETA PLUS Pharma
Brussels, Belgium
UZ
Brussels, Belgium
CHU
Liege, Belgium

Monrol Bulgaria
Sofia, Bulgaria
Cyclopharma
Caen, France
Cyclopharma
Dijon, France

Cyclopharma
Glicy, France
Centre d’Imagerie Moleculaire
Guadeloupe, France
Cyclopharma
Lyon, France

Cyclopharma
Marseille, France
Cyclopharma
Nice, France
Cyclopharma
St. Beauzire, France

Cyclopharma
Strasbourg, France
Cyclopharma
Toulouse, France
Cyclopharma
Tours, France

NRoCK
Kiel, Germany
PET Medicopus Diagnosztikai és Kutatò
Kaposvar, Hungary
M2i
Dublin, Ireland

Az. Osp. G. Brotzu
Cagliari, Italy
Az. Osp. Cannizzaro
Catania, Abruzzo, Italy
Tecnomed
Monza (MI), Italy

I.R.C.C.S. Pascale
Napoli, Campania, Italy
S.D.N.
Napoli, Italy
Ospedale
Negrar (VR), Italy

Policlinico Gemelli
Roma, Lazio, Italy
AOU Senese
Siena, Italy
Leids Universitair Medisch Centrum
Leiden, Netherlands

HIL
Warsaw, Poland
Monrol Poland
Warsaw, Poland
University
Warsaw, Poland

Monrol Romania
Bucharest, Romania
BIONT
Bratislava, Slovakia
UKC
Ljubljana, Slovenia

Hospital de Vall d’Hebron
Barcelona, Spain
IRAB
Barcelona, Spain
SWAN Isotopen
Bern, Switzerland

UCL
London, United Kingdom of Great Britain and Northern Ireland
Churchill Hospital
Oxford, United Kingdom of Great Britain and Northern Ireland

ASIA

Jiang Xi Prov. Hospital
NanChang City, China
GMC&H
Guwahati, India
AIIMS
New Delhi, India

HDX Busan
Busan, Republic of Korea
Chonnam National University Hospital
Gwangju, Republic of Korea
Jeju National University Hospital
Jeju, Republic of Korea

Chonnam National University Hwasun Hospital
Jeonnam, Republic of Korea
NCC
Seoul, Republic of Korea
Yonsei Severance Hospital
Seoul, Republic of Korea

Kurchatov Institute
Moscow, Russian Federation

OCEANIA

SAHMRI
Adelaide, Australia
C.A.I
Brisbane, Australia
RBWH
Brisbane, Australia

© 2019 TEMA SINERGIE S.p.A
Fiscal Code n. 00970310397
Business Register of Ravenna n. 00970310397  |  R.E.A. 111877
Capital Stock € 2.000.000,00 paid-up